ZA200702093B - Arene ruthenium (II) compounds and their use in cancer therapy - Google Patents

Arene ruthenium (II) compounds and their use in cancer therapy

Info

Publication number
ZA200702093B
ZA200702093B ZA200702093A ZA200702093A ZA200702093B ZA 200702093 B ZA200702093 B ZA 200702093B ZA 200702093 A ZA200702093 A ZA 200702093A ZA 200702093 A ZA200702093 A ZA 200702093A ZA 200702093 B ZA200702093 B ZA 200702093B
Authority
ZA
South Africa
Prior art keywords
compounds
cancer therapy
arene ruthenium
arene
ruthenium
Prior art date
Application number
ZA200702093A
Inventor
Habtemariam Abraha
Sadler Peter John
Original Assignee
Univ Edinburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Edinburgh filed Critical Univ Edinburgh
Publication of ZA200702093B publication Critical patent/ZA200702093B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
    • C07F15/0046—Ruthenium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
ZA200702093A 2004-08-20 2007-03-12 Arene ruthenium (II) compounds and their use in cancer therapy ZA200702093B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0418643.3A GB0418643D0 (en) 2004-08-20 2004-08-20 Ruthenium (II) compounds

Publications (1)

Publication Number Publication Date
ZA200702093B true ZA200702093B (en) 2008-08-27

Family

ID=33042406

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200702093A ZA200702093B (en) 2004-08-20 2007-03-12 Arene ruthenium (II) compounds and their use in cancer therapy

Country Status (12)

Country Link
EP (1) EP1786412A1 (en)
JP (1) JP2008510693A (en)
KR (1) KR20070060091A (en)
CN (1) CN101043885A (en)
AU (1) AU2005273726A1 (en)
BR (1) BRPI0514430A (en)
CA (1) CA2578280A1 (en)
GB (1) GB0418643D0 (en)
MX (1) MX2007002099A (en)
NO (1) NO20071481L (en)
WO (1) WO2006018649A1 (en)
ZA (1) ZA200702093B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006017594A1 (en) * 2006-04-13 2007-10-18 Wacker Chemie Ag Novel Ru complexes, their preparation and use
WO2007128158A1 (en) 2006-05-09 2007-11-15 Ecole Polytechnique Federale De Lausanne (Epfl) Transition metal complexes for inhibiting resistance in the treatment of cancer and metastasis
GB0711849D0 (en) * 2007-06-19 2007-07-25 Oxford Biosensors Ltd Redox Mediators
EP2067771A1 (en) 2007-12-03 2009-06-10 EPFL Ecole Polytechnique Fédérale de Lausanne Derivatives of Dihydroxypyrrolidine as Anti-Cancer Compounds
EP2409697A1 (en) 2010-07-20 2012-01-25 Université de Neuchâtel Medicaments Based on Dinuclear Ruthenium, Osmium and Iron Complexes Comprising Triply Bridging Thiolato, Selenolato, Alkoxo and/or Amido Ligands
WO2013038395A1 (en) 2011-09-16 2013-03-21 Universidade De Lisboa Transition metal complexes for pharmaceutical applications
WO2013136296A2 (en) 2012-03-14 2013-09-19 Universidade De Lisboa Water-soluble organometallic ruthenium and iron compunds presenting heteroaromatic ligands
CA2907356C (en) 2013-03-15 2022-07-12 Sherri Ann MCFARLAND Metal-based coordination complexes as photodynamic compounds and their use
US9751081B2 (en) 2014-12-01 2017-09-05 Clemson University Self-regenerating antioxidant catalysts and methods of using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19736152A1 (en) * 1997-08-14 1999-02-18 Martin Wehlan New azido-aziridine complex compounds
EP1224192B1 (en) * 1999-10-27 2005-08-31 The University Court, The University Of Edinburgh Half-sandwich ruthenium (ii) compounds comprising nitrogen containing ligands for treatment of cancer
GB0016052D0 (en) * 2000-06-30 2000-08-23 Univ Edinburgh Ruthenium (II) compounds
GB0215526D0 (en) * 2002-07-05 2002-08-14 Univ Edinburgh Anticancer compounds

Also Published As

Publication number Publication date
CA2578280A1 (en) 2006-02-23
KR20070060091A (en) 2007-06-12
BRPI0514430A (en) 2008-05-06
CN101043885A (en) 2007-09-26
AU2005273726A1 (en) 2006-02-23
WO2006018649A1 (en) 2006-02-23
GB0418643D0 (en) 2004-09-22
MX2007002099A (en) 2007-04-24
EP1786412A1 (en) 2007-05-23
JP2008510693A (en) 2008-04-10
NO20071481L (en) 2007-05-16

Similar Documents

Publication Publication Date Title
IL178012A0 (en) Diphenyl-indol-2-on compounds and their use in the treatment of cancer
IL182652A0 (en) Nitrobenzindoles and their use in cancer therapy
HK1136822A1 (en) Therapeutic compounds and their use in cancer
IL172316A0 (en) Novel compounds and their use in therapy
ZA200702093B (en) Arene ruthenium (II) compounds and their use in cancer therapy
PL379553A1 (en) Vanilloid receptor ligands and their use in treatments
IL174994A0 (en) Pyrimidin - 4 - yl - 3, 4 - thione compounds and their use in therapy
EP1749095A4 (en) Novel therapeutic targets in cancer
AU2003293376A8 (en) Anti-angiogenic compounds and their use in cancer treatment
IL173576A0 (en) Use of polypeptides of the cupredoxin family in cancer therapy
GB0523576D0 (en) Drug composition and its use in therapy
GB0324761D0 (en) Use of compounds in therapy
GB0418328D0 (en) Cancer methods and medicaments
HK1105886A1 (en) Pharmaceutical compositions comprising l-733060 for use in the treatment of cancer tumours l-733060
GB0400700D0 (en) Compounds useful in therapy
ZA200709542B (en) Combination therapy in the treatment of cancer
EP1778873A4 (en) Novel therapeutic targets in cancer
GB0428170D0 (en) Mono and Combination Therapy
GB0326578D0 (en) Cancer diagnosis and therapy
IL185575A0 (en) Benzoxazocines and their therapeutic use
GB0700827D0 (en) Hai-1 and Hai-2 in cancer therapy
IL175774A0 (en) Use of siramesine in the treatment of cancer
EP1816136A4 (en) Gpr7-selective ligand and use thereof
GB0421917D0 (en) Cancer diagnosis and therapy
GB0423117D0 (en) Compounds for use in therapy